Daily Judi: Tuesday, March 14, 2023
Every day we scan the headlines for the best items that engage the clinical trial ecosystem, workflow solutions, and more—all the latest news you need to know. Here are today's stories:
Following a similar move by Eli Lilly, Novo Nordisk announced that starting in 2024, it will lower the price of certain insulin products in the United States by up to 75%.
(NBC News)
Kevin Dunleavy reports that the U.S. Veterans Health Administration will cover Eisai and Biogen’s new Alzheimer’s treatment, Leqembi, allowing access to veterans in early stages of the disease. (Fierce Pharma)
In the first of a two-part series of “Intention to Treat,” from the New England Journal of Medicine, Rachel Gotbaum speaks with friends, family, and colleagues of Dr. Anthony Fauci, about his years of service at the NIH.
Our Culture
“We are small enough that we are nimble, so we can prioritize quickly, yet also of significant size that we allocate resources where needed. We truly do a lot. This is my dream job. Judi allows me to have a bigger impact. And we do great work.”
–Jess, Program Manager
About Judi
Judi speeds and improves the world's clinical trial workflows. Our cloud-based platform has 120,000 users across 171 countries. We eliminate the chaos so clinical teams can focus on the patient, rather than the process. We are a SOC 2 certified collaboration platform.
